http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6327463-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e3324a35e1615e6eede6df1be26b7dd
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C217-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C213-00
filingDate 1986-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d94b6a498efa071a47875992a762984f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b93615a4adb54482c1e3abcf0ce96025
publicationDate 1988-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S6327463-A
titleOfInvention Production of deacetyl moxisylyte
abstract PURPOSE: To obtain the titled compound having sympathetic nerve suppressing action and useful as a synthetic intermediate for cerebral circulation improver, with simple process, by oxidizing thymol with persulfuric acid, reacting with dimethylaminoethyl chloride and hydrolyzing the reaction product. n CONSTITUTION: Thymol of formula I is made to react with persulfuric acid at 0W40°C in a solvent such as water-acetone in the presence of an alkali to obtain a phenyl sulfite derivative, which is converted to an ether compound of formula II by reacting with dimethylaminoethyl chloride in a solvent such as dioxane in the presence of an alkali at a temperature between 50°C and the boiling point of the solvent. The ether is hydrolyzed e.g. with hydrochloric acid at 60W100°C to obtain the objective compound of formula III. The amount of persulfuric acid is 1W1.5mol per 1mol of thymol. n COPYRIGHT: (C)1988,JPO&Japio
priorityDate 1986-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227058246
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226812218
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415715485
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24413
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18366337
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226776033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11390667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410492491
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419519719
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14972829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451609951
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14597426
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6989
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7901
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID28093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414016505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487935

Total number of triples: 39.